Loading…

Human Milk Oligosaccharides Support Normal Bowel Function and Improve Symptoms of Irritable Bowel Syndrome: A Multicenter, Open-Label Trial

INTRODUCTION: Treatment options for irritable bowel syndrome (IBS) are limited, causing many patients to remain symptomatic. This study assessed the potential of human milk oligosaccharides (HMOs) to normalize bowel habits. Secondary outcomes included IBS severity and health-related quality of life....

Full description

Bibliographic Details
Main Authors:	Palsson, Olafur S., Peery, Anne, Seitzberg, Dorthe, Amundsen, Ingvild Dybdrodt, McConnell, Bruce, Simrén, Magnus
Format:	Online Article Text
Language:	English
Published:	Wolters Kluwer 2020
Subjects:	Article
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721220/ https://www.ncbi.nlm.nih.gov/pubmed/33512807 http://dx.doi.org/10.14309/ctg.0000000000000276

Similar Items

The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome
by: Iribarren, Cristina, et al.
Published: (2021)

Randomised clinical trial: individual versus group hypnotherapy for irritable bowel syndrome
by: Lövdahl, Jenny, et al.
Published: (2022)

Irritable Bowel Syndrome
by: Farup, Per G., et al.
Published: (2012)

The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome
by: Sanz Morales, Patricia, et al.
Published: (2022)

Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
by: Tornkvist, Navkiran T., et al.
Published: (2021)

Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome
by: Bennet, Sean M.P., et al.
Published: (2015)

Association between Brachyspira and irritable bowel syndrome with diarrhoea
by: Jabbar, Karolina S, et al.
Published: (2021)

The Dietary Management of Patients with Irritable Bowel Syndrome: A Narrative Review of the Existing and Emerging Evidence
by: Algera, Joost, et al.
Published: (2019)

Irritable bowel syndrome with food‐related symptoms: Future directions in the clinical management
by: Melchior, Chloé, et al.
Published: (2022)

Type of Rectal Barostat Protocol Affects Classification of Hypersensitivity and Prediction of Symptom Severity in Irritable Bowel Syndrome
by: Josefsson, Axel, et al.
Published: (2022)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
by: Padhy, Susanta Kumar, et al.
Published: (2015)

Development of an educational intervention for patients with Irritable Bowel Syndrome (IBS) – a pilot study
by: Ringström, Gisela, et al.
Published: (2009)

A Distinct Faecal Microbiota and Metabolite Profile Linked to Bowel Habits in Patients with Irritable Bowel Syndrome
by: Ahluwalia, Bani, et al.
Published: (2021)

Irritable bowel syndrome: Factors of importance for disease‐specific quality of life
by: Melchior, Chloé, et al.
Published: (2022)

Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms
by: Midenfjord, Irina, et al.
Published: (2020)

Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial
by: Gaylord, Susan A, et al.
Published: (2009)

Prevalence, epidemiology and associated healthcare burden of Rome IV irritable bowel syndrome and functional dyspepsia in the adult population of Gibraltar
by: Kovács, Dénes Botond, et al.
Published: (2022)

Habitual FODMAP Intake in Relation to Symptom Severity and Pattern in Patients with Irritable Bowel Syndrome
by: Nybacka, Sanna, et al.
Published: (2020)

Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome
by: Tap, Julien, et al.
Published: (2021)

Fasting breath H(2) and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome
by: Le Nevé, Boris, et al.
Published: (2019)

The Role of Carbohydrates in Irritable Bowel Syndrome: Protocol for a Randomized Controlled Trial Comparing Three Different Treatment Options
by: Nybacka, Sanna, et al.
Published: (2022)

Low fermentable oligosaccharides, disaccharides, monosaccharides, and polypols diet and irritable bowel syndrome in Asia
by: Zhang, Yihe, et al.
Published: (2018)

Predictors of Symptom-Specific Treatment Response to Dietary Interventions in Irritable Bowel Syndrome
by: Colomier, Esther, et al.
Published: (2022)

Changes in serum and urinary metabolomic profile after a dietary intervention in patients with irritable bowel syndrome
by: Nybacka, Sanna, et al.
Published: (2021)

Randomised controlled trial: effects of gluten‐free diet on symptoms and the gut microenvironment in irritable bowel syndrome
by: Algera, Joost P., et al.
Published: (2022)

Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
by: Tack, Jan, et al.
Published: (2019)

Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia
by: Kanazawa, Motoyori, et al.
Published: (2015)

Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome
by: Frändemark, Åsa, et al.
Published: (2022)

Associations between postprandial symptoms, hydrogen and methane production, and transit time in irritable bowel syndrome
by: Algera, Joost P., et al.
Published: (2022)

Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J)
by: Kanazawa, Motoyori, et al.
Published: (2007)

Galacto-oligosaccharides and bowel function
by: Niittynen, Leena, et al.
Published: (2007)

The Serum Metabolite Response to Diet Intervention with Probiotic Acidified Milk in Irritable Bowel Syndrome Patients Is Indistinguishable from that of Non-Probiotic Acidified Milk by (1)H NMR-Based Metabonomic Analysis
by: Pedersen, Simon M. M., et al.
Published: (2010)

Defining the irritable bowel
by: Chuah, Kee Huat, et al.
Published: (2022)

Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice
by: Simren, Magnus, et al.
Published: (2017)

Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids
by: Iribarren, Cristina, et al.
Published: (2022)

Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome
by: Sundin, Johanna, et al.
Published: (2020)

Increased Postprandial Colonic Motility and Autonomic Nervous System Activity in Patients With Irritable Bowel Syndrome: A Prospective Study
by: Tanaka, Yukari, et al.
Published: (2018)

Association between pain sensitivity and gray matter properties in the sensorimotor network in women with irritable bowel syndrome
by: Grinsvall, Cecilia, et al.
Published: (2020)

Irritable bowel syndrome, inflammatory bowel disease and the microbiome
by: Major, Giles, et al.
Published: (2014)

Is irritable bowel syndrome a dysbiotic bowel syndrome?
by: Benno, Peter, et al.
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0e5gbollor6fumtrf62sfknoa3